Join us at AACR Annual Meeting 2017
In addition to the traditional National Cherry Blossom Festival, this spring Washington, D.C. will welcome the AACR Annual Meeting 2017 on April 1-5!
We’ll be delighted to meet you at our booth (#1643) where you can learn more about our solutions dedicated to cancer research and biomarker discovery. We’ll feature our complete portfolio of products dedicated to cancer research and biomarker testing.
- Automated and manual sample preparation
- NGS kits and quality control
- Gene expression and miRNA regulation
- Pathway analysis and epigenetics
- Solid tumor and blood cancer biomarkers
Meet our experts and discuss sample prep, NGS kits and quality control, gene expression and miRNA regulation, pathway analysis and epigenetics, and solid tumor and blood cancer biomarkers.
We’re also hosting a Spotlight theater presentation and presenting several posters. Check out the following for details.
Spotlight theater presentation
Topic: Achieving NGS insights using QIAGEN ‘Now Generation’ technologies
Date/time: 10:00 a.m., Tuesday, April 4
Location: Spotlight Theater A, Exhibit Hall A
Guest speaker: Monika Mehta, Ph.D., R&D Scientist, Sequencing Facility, Frederick National Laboratory for Cancer Research (FNLCR), Leidos Biomedical Research, Inc., Advanced Technology Research Facility, Frederick, MD
Poster presentations
Topic 1: Integrative approach to biomarker discovery by performing comparative analysis of two cancers, hepatocellular carcinoma and endometrioid endometrial carcinoma, using genetics and transcriptomics from RNA sequencing data
Date/time: Monday, April 3 – 1:00 p.m. – 5:00 p.m.
Location: Section 39, 2840 / 13
Topic 2: RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients
Date/time: Tuesday, April 4 – 8:00 a.m. – 12:00 p.m.
Location: Section 31, 3777 / 3
Topic 3: RNA fusion detection in thyroid nodules with a targeted RNA sequencing panel
Date/time: Wednesday, April 5 – 8:00 a.m. – 12:00 p.m.
Location: Section 17, 5408 / 19
We look forward to seeing you there.